Author guidelines
Electronic Journal of Medical Research (EJMR) Print ISSN 3106-1362 | Online ISSN 3106-1370 | Published by RES Publishers
1. Introduction
The Electronic Journal of Medical Research (EJMR) is an international, peer-reviewed, open-access journal published quarterly. The journal provides a scholarly platform for researchers, clinicians, healthcare professionals, academics, and other contributors to disseminate high-quality research across the medical and health sciences.
EJMR publishes original and scientifically rigorous work that contributes to the advancement of medical knowledge, clinical practice, biomedical sciences, public health, and related disciplines. Manuscripts are considered on the basis of their scientific quality, originality, methodological rigor, ethical standards, relevance, and contribution to the journal's readership.
Authors are encouraged to review the journal's Aims and Scope before submitting a manuscript to ensure that their work is appropriate for EJMR.
Categories of Manuscripts
EJMR considers the following categories of manuscripts:
a. Research papers (experimental and clinical)
b. Letters to the Editor
c. Review articles, including systematic reviews and meta-analyses
d. Editorials
e. Case reports and case series
a. Research Papers (Experimental and Clinical)
Research papers should report original, scientifically sound research relevant to the medical and health sciences. Manuscripts should normally not exceed ten printed pages, where one printed page corresponds approximately to 800 words or the equivalent amount of illustrative and tabular material.
The manuscript should generally be presented in the following order:
-
Title page
-
Abstract
-
Keywords
-
Introduction
-
Materials and Methods
-
Results
-
Discussion
-
Conclusion, where appropriate
-
Declarations
-
References
-
Figure legends
-
Tables
The abstract should not exceed 250 words. Abbreviations should be kept to a minimum, and references should not be cited in the abstract.
The Introduction should concisely describe the background and significance of the study, identify the relevant knowledge gap, and conclude with a clearly stated study objective or research question.
The Materials and Methods section should provide sufficient information to permit appropriate evaluation and, where applicable, replication of the study.
The Results section should present the principal findings clearly and objectively. Tables and figures should be used where they improve presentation and understanding. Authors should avoid unnecessary duplication of numerical information between the text, tables, and figures.
The Discussion should interpret the principal findings in relation to existing evidence, discuss their implications and limitations, and avoid unnecessary repetition of the Results. The manuscript should conclude with a clear statement reflecting the principal findings and, where appropriate, their clinical, scientific, or public health relevance.
Clinical and Health Research Reporting
Research involving human participants must comply with internationally recognized ethical principles, including the Declaration of Helsinki, and with applicable national and institutional requirements.
Authors should follow the appropriate reporting guideline for their study design. Examples include:
| Study design | Guideline |
|---|---|
| Randomised parallel or crossover trials | CONSORT |
| Observational studies | STROBE |
| Case reports | CARE |
| Systematic reviews and meta-analyses | PRISMA |
| Meta-analyses of observational studies | MOOSE |
| Diagnostic accuracy studies | STARD |
| Qualitative research | COREQ |
Authors are encouraged to consult the EQUATOR Network to identify the most appropriate reporting guideline for their study.
Where a reporting guideline provides a checklist and/or flow diagram, authors should submit the applicable documents with the manuscript.
Clinical Trial Registration
Clinical trials must be registered prospectively in an appropriate, publicly accessible clinical trial registry. The registry name and registration number must be provided in the manuscript.
The Methods section must identify the research ethics committee or institutional review board that approved the study, including the approval/reference number where available.
If a trial was registered retrospectively, the authors must provide a clear explanation. The editorial team reserves the right to determine whether a retrospectively registered trial is eligible for consideration.
b. Letters to the Editor
Letters to the Editor are intended for concise, constructive discussion of work published in EJMR or for presenting scientifically relevant observations or ideas.
Letters do not require an abstract and normally should not exceed:
-
three double-spaced pages;
-
two figures and/or two tables; and
-
25 references.
Letters generally should not be divided into Introduction, Methods, Results, and Discussion sections.
Short research reports may occasionally be considered in this format at the discretion of the Editor.
c. Review Articles
Review articles provide a comprehensive and critical synthesis of the literature on a topic relevant to the journal's scope. Reviews may be invited by the Editors; unsolicited review articles are also welcome.
Review articles will normally be limited to 20,000 words excluding references and should not present previously unpublished primary research data.
The manuscript should generally contain:
-
Title page
-
Abstract
-
Keywords
-
Introduction
-
Relevant main sections and subsections
-
Discussion
-
Conclusions
-
Future directions, where appropriate
-
Declarations
-
References
-
Figure legends
-
Tables
Systematic Reviews and Meta-Analyses
Systematic reviews and meta-analyses must use transparent and reproducible methods to identify, select, critically appraise, synthesize, and, where applicable, quantitatively analyze relevant evidence.
Systematic reviews and meta-analyses must follow the appropriate reporting guidelines, including PRISMA or MOOSE, where applicable.
The appropriate checklist should be submitted as supplementary material, and the flow diagram should be included with the manuscript.
Authors are strongly encouraged to prospectively register systematic review protocols in an appropriate public registry such as PROSPERO, where eligible. Registration information should be reported in the manuscript.
d. Editorials
Editorials are generally written by the Editor-in-Chief, members of the Editorial Board, or invited experts. Editorials do not have a fixed format and are published at the discretion of the journal.
e. Case Reports and Case Series
Case reports and case series should describe rare, unusual, novel, or educationally important clinical cases that contribute meaningfully to medical knowledge or clinical practice.
Authors should follow the CARE reporting guideline, where applicable.
Written informed consent for publication must be obtained from the patient or, where appropriate, the patient's legally authorized representative. Identifying information should be omitted unless it is scientifically necessary and explicit consent for its publication has been obtained.
The manuscript should include relevant diagnostic and clinical information and a discussion explaining the significance of the case in relation to existing literature.
2. Editorial Policy
For additional information regarding editorial procedures and decision-making, authors should review the journal's Editorial Policy.
2.1. Originality
EJMR is committed to maintaining high standards of research and publication integrity.
Manuscripts are evaluated according to their scientific quality, originality, methodological validity, reliability of the data, reproducibility where applicable, ethical compliance, relevance to the journal's scope, and contribution to the scientific or clinical literature.
Submission of a manuscript to EJMR confirms that:
-
the manuscript represents original work;
-
it has not previously been published in substantially the same form;
-
it is not simultaneously under consideration by another journal; and
-
all authors have approved its submission to EJMR.
Redundant, duplicate, or substantially overlapping publication must be disclosed to the Editorial Office at submission.
2.2. Authorship
All listed authors must meet recognized authorship criteria and must have made substantial contributions to the work.
Before submission, all authors must approve:
-
the final manuscript;
-
the order in which authors are listed;
-
their individual contributions; and
-
submission of the manuscript to EJMR.
The corresponding author is responsible for communication with the journal throughout submission, peer review, revision, and publication and must ensure that all authors are appropriately informed.
Requests to add, remove, or reorder authors after submission must include an explanation and written agreement from all affected authors. Such requests will be evaluated in accordance with the journal's Authorship Contribution Policy and relevant COPE guidance.
Guest, gift, and ghost authorship are not permitted.
2.3. Ethical Considerations and Compliance with Ethical Standards
EJMR is committed to responsible research and publication practices. Authors must comply with the journal's publication ethics policies and all applicable institutional, national, and international ethical requirements.
Authors are responsible for ensuring the originality and integrity of all text, data, figures, tables, images, and other materials included in their manuscript.
Material reproduced or adapted from previously published sources must be appropriately cited and, where required, permission must be obtained from the copyright holder.
For further information, authors should review the journal's Publication Ethics and Publication Ethics and Malpractice Statement.
Where applicable, manuscripts should include a Declarations section containing:
-
Acknowledgements;
-
Conflict of Interest;
-
Funding;
-
Authors' Contributions;
-
Ethics Approval;
-
Informed Consent;
-
Consent for Publication, where applicable; and
-
Data Availability.
2.4. Conflict of Interest Disclosure
All authors must disclose any financial or non-financial interests that could reasonably be perceived as influencing the work.
Potential competing interests may include financial, commercial, institutional, academic, professional, or personal relationships.
A Conflict of Interest statement must be included in the manuscript even when the authors have no conflicts to declare.
For more information, see the Conflicts of Interest Policy.
2.5. Human and Animal Research
Human Subject Research
Studies involving human participants, human biological material, or identifiable human data must have received appropriate approval from an institutional review board, research ethics committee, or equivalent body before the study commenced, unless a documented exemption applies.
The manuscript should state:
-
the name of the approving ethics committee or institutional review board;
-
the approval/reference number, where available;
-
the ethical standards under which the study was conducted; and
-
the process used to obtain informed consent, where applicable.
The privacy, dignity, confidentiality, and rights of research participants must be protected.
Animal Research
Research involving animals must comply with applicable institutional, national, and international standards governing the humane care and use of animals.
The manuscript should identify the approving research ethics or animal-care committee and provide the approval/reference number where available.
Authors should provide sufficient methodological information concerning animal care, anesthesia, analgesia, and experimental procedures where relevant.
Informed Consent and Consent for Publication
Written informed consent must be obtained where required for participation in research.
Where a manuscript contains identifiable information about an individual—including photographs, clinical images, videos, or detailed case information- written consent for publication must also be obtained from the participant or an appropriate legally authorized representative.
Authors must protect participant confidentiality and remove unnecessary identifying information.
2.6. Plagiarism Prevention
EJMR is committed to protecting the integrity of the scholarly record.
Submitted manuscripts may be screened for textual similarity using Crossref Similarity Check powered by iThenticate or other appropriate integrity-screening tools.
Authors are responsible for ensuring that:
-
the manuscript is original;
-
all sources are appropriately cited;
-
quotations and reproduced material are clearly identified;
-
permission has been obtained where required; and
-
previously published work by the authors is appropriately cited and not presented as new work.
A similarity report is an editorial screening tool and is not, by itself, evidence of plagiarism. Potential cases are assessed by the editorial team according to the nature, extent, and context of the overlap.
For further information, see the Plagiarism Prevention Policy.
3. Preparation of Manuscript
Free Format Submission
The Electronic Journal of Medical Research offers Free Format submission to simplify the initial submission process.
At initial submission, authors may submit an editable manuscript containing the text, tables, and figures in a single file or as separate files.
The manuscript should contain all sections required for the relevant article type. Figures and tables must include appropriate titles or legends and should be of sufficient quality to permit scientific evaluation.
References may be submitted initially in any recognized reference style provided that the style is applied consistently throughout the manuscript. Following peer review and before final acceptance, authors may be required to format references according to EJMR's prescribed AMA style.
Supporting information should be uploaded separately where appropriate.
Manuscripts that are incomplete, illegible, poorly prepared, or written in language that substantially prevents scientific evaluation may be returned to the authors before peer review.
Information Required at Submission
Authors should provide:
-
the complete manuscript;
-
full author names;
-
institutional affiliations;
-
email addresses;
-
ORCID IDs, where available;
-
corresponding-author information; and
-
all relevant declarations.
Declarations may include:
-
Data Availability Statement;
-
Funding Statement;
-
Authors' Contribution Statement;
-
Conflict of Interest Disclosure;
-
Ethics Approval Statement;
-
Informed Consent Statement;
-
Consent for Publication;
-
Clinical Trial Registration, where applicable; and
-
Permission to reproduce material from other sources.
To submit a manuscript, authors should log in to the journal's online submission system and follow the submission steps.
Manuscript Template
Following peer review, when a revision is requested, authors should use the EJMR manuscript template and prepare the revised manuscript in accordance with the journal's formatting requirements.
Manuscripts should be scientifically rigorous, clearly written, concise, and appropriately structured.
3.1. Manuscript Text
Manuscripts should be prepared in an editable word-processing format. Text should normally be double-spaced and presented consistently throughout the document.
Authors should avoid unnecessary formatting and ensure that symbols, numbers, units, abbreviations, and special characters are used consistently.
3.2. Title Page
The title page should contain:
-
The complete title of the manuscript;
-
Full names of all authors;
-
Complete institutional affiliations;
-
ORCID IDs, where available;
-
Email addresses; and
-
Identification of the corresponding author, including email address and appropriate contact details.
Title
The title should be concise, informative, and accurately reflect the principal content of the manuscript.
Authors should avoid:
-
non-standard abbreviations;
-
unnecessary symbols;
-
overly general wording; and
-
redundant introductory phrases such as “A study of...,” “Investigation of...,” or “Observations on...”.
Abstract
The abstract should accurately summarize the study and should not normally exceed 250 words.
For original research articles, a structured abstract may be used where appropriate to the study design and should clearly summarize the background/objective, methods, results, and conclusion.
For article types for which a specific abstract structure is prescribed, such as systematic reviews, the applicable reporting guideline should be followed.
References, figures, and tables should not be cited in the abstract. Abbreviations should be minimized and defined when necessary.
Keywords
Authors should provide four to seven keywords that accurately represent the manuscript's content and facilitate indexing and retrieval.
Where appropriate, authors are encouraged to use standardized terminology such as Medical Subject Headings (MeSH).
3.3. Introduction
The Introduction should provide sufficient background to explain the scientific or clinical context of the study, identify the relevant knowledge gap, and clearly state the objective, hypothesis, or research question.
3.4. Materials and Methods
The Materials and Methods section should provide sufficient detail to allow readers to evaluate the validity of the study and, where applicable, enable replication.
Authors should clearly describe:
-
study design;
-
setting and participants;
-
inclusion and exclusion criteria;
-
sampling procedures;
-
interventions or exposures;
-
outcome measures;
-
laboratory or experimental procedures;
-
statistical analyses;
-
ethical approval; and
-
other methodological information relevant to the study.
New procedures should be described in sufficient detail. Previously published methods may be summarized with appropriate citation.
Sources and specifications of important equipment, reagents, software, or biological materials should be provided where relevant.
3.5. Results
The Results section should present the study findings clearly, accurately, and objectively.
Results may be presented using text, tables, and figures. Authors should avoid unnecessary duplication of the same data across multiple formats.
Statistical results should be reported with appropriate measures of precision and uncertainty where relevant.
3.6. Discussion
The Discussion should interpret the principal findings rather than merely repeat the Results.
Authors should:
-
relate the findings to existing literature;
-
discuss their scientific, clinical, or public health implications;
-
address relevant strengths and limitations;
-
avoid conclusions not supported by the data; and
-
identify appropriate implications for future research where relevant.
A clear conclusion should summarize the principal message of the study.
The Results and Discussion sections may be combined where appropriate for the manuscript type.
3.7. Tables
Tables must be editable and should preferably be provided in Word or Excel format rather than as images.
Each table should:
-
be numbered consecutively;
-
be cited in the text in numerical order;
-
have a concise and informative title;
-
contain clearly labelled columns and rows;
-
identify measurement units;
-
include explanatory footnotes where necessary; and
-
define all abbreviations used.
Footnotes may be indicated using superscript lowercase letters or other consistent symbols.
3.8. Figures
Figures should be of sufficient quality and resolution for publication and should be submitted separately when requested.
Each figure should:
-
be numbered consecutively;
-
be cited in the text in numerical order;
-
include an informative legend;
-
contain clearly labelled axes and measurement units where applicable; and
-
avoid unnecessary manipulation or enhancement.
For figures containing multiple panels, panels should be clearly identified as A, B, C, D, etc.
Acceptable file formats include:
-
JPEG (.jpg); and
-
PNG.
A minimum resolution of 300 dpi is recommended for appropriate figures.
Authors are responsible for obtaining written permission to reproduce or adapt previously published figures, tables, or other copyrighted material where such permission is required. The original source and copyright status must be clearly acknowledged.
3.9. Declarations
The following statements should be included immediately before the References, as applicable.
Acknowledgements
Individuals who contributed to the work but do not meet authorship criteria may be acknowledged with their permission.
Financial support should be reported under the Funding statement rather than solely in the Acknowledgements.
Conflict of Interest
All authors must disclose any relevant competing interests.
If no competing interests exist, authors should state:
Conflict of Interest: The authors declare no conflicts of interest.
For further information, see the Conflicts of Interest Policy.
Authors' Contributions
All listed authors must meet the journal's authorship criteria.
Authors should describe their individual contributions to the research and manuscript. Where appropriate, the CRediT Contributor Roles Taxonomy may be used.
The corresponding author is responsible for ensuring that all authors approve the final manuscript and agree to be accountable for the integrity of the work.
For further details, see the Authorship Contribution Policy.
Funding
Authors must identify all sources of financial support for the research and/or preparation of the manuscript and provide grant numbers where applicable.
The role of the funder in study design, data collection, analysis, interpretation, manuscript preparation, and the decision to submit for publication should be disclosed where relevant.
Example:
Funding: This work was supported by [name of funding organization] [grant number XXXX].
If the research received no specific funding, authors may state:
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Ethics Approval
For research requiring ethical approval, authors should state the name of the approving ethics committee or institutional review board and the approval/reference number where available.
If ethical approval was not required, authors should provide an appropriate statement where relevant.
Informed Consent
For research involving human participants, authors must state whether informed consent was obtained or whether an appropriate ethics committee granted a waiver.
Informed consent does not apply to animal research.
Consent for Publication
Where identifiable information about an individual is included, authors must confirm that appropriate consent for publication was obtained.
Data Availability
Authors should include a Data Availability Statement explaining whether and how the data supporting the findings can be accessed.
Where data have been deposited in a repository, authors should provide the repository name, persistent identifier, DOI, accession number, or appropriate link.
Where data cannot be publicly shared because of ethical, legal, privacy, or confidentiality restrictions, the reason should be stated.
3.10. References
References should be numbered consecutively in the order in which they first appear in the text rather than alphabetically.
References cited in the text, tables, and figure legends should be identified using superscript Arabic numerals.
Authors are responsible for the accuracy and completeness of all references and citations.
Where available, the DOI should be provided as a persistent DOI link.
For the final accepted manuscript, references must follow the AMA (American Medical Association) style.
Journal titles should be abbreviated according to the NLM Catalog or the List of Title Word Abbreviations (LTWA).
For references with up to six authors, list all authors. For references with more than six authors, list the first three followed by et al.
Journal references should include the year, volume, issue where applicable, and page range or article number.
Journal Article
Author AA, Author BB, Author CC. Title of article. Abbreviated Journal Title. Year;Volume(Issue):Pages. doi:DOI
Online Journal Article
Author AA, Author BB, Author CC, et al. Title of article. Abbreviated Journal Title. Year;Volume(Issue):Pages. doi:DOI
Online Article Without DOI
Author AA, Author BB. Title of article. Journal Title. Year;Volume(Issue):Pages. URL. Accessed Month Day, Year.
Book
Author AA, Author BB. Title of Book. Edition. Publisher; Year.
Chapter in an Edited Book
Author AA, Author BB. Title of chapter. In: Editor AA, Editor BB, eds. Title of Book. Edition. Publisher; Year:Pages.
Patent
Inventor AA, Inventor BB. Title of patent. Country Patent Number. Publication year.
Website
Author/Organization. Title of webpage. Website name. URL. Published/updated date, if available. Accessed Month Day, Year.
The reference list should contain only works cited in the manuscript and published or formally accepted for publication. Personal communications and unpublished observations should generally be cited only in the text, with appropriate permission where necessary.
Nomenclature
Internationally accepted nomenclature should be used for chemical and biochemical agents, microorganisms, genes, proteins, enzymes, and other scientific terms.
Abbreviations
Abbreviations should be defined at first use and used consistently thereafter. Non-standard abbreviations should be minimized.
4. Submission of Manuscripts
Manuscripts must be submitted exclusively through the EJMR online submission system.
Authors can begin a submission through the Article Submission Portal.
Manuscripts submitted by email are not considered formal submissions.
The corresponding author must provide an active email address. Editorial correspondence, peer-review notifications, revision requests, proofs, and publication communications will normally be conducted electronically.
4.1. Cover Letter
A cover letter should accompany the manuscript and confirm that:
-
the manuscript is original;
-
it has not previously been published in substantially the same form;
-
it is not currently under consideration by another journal;
-
all authors have approved the manuscript and its submission to EJMR;
-
all individuals who qualify for authorship have been appropriately listed;
-
relevant competing interests have been disclosed; and
-
permissions have been obtained for copyrighted material where required.
Authors should also identify any information relevant to editorial assessment, including related manuscripts, preprints, clinical trial registration, or other matters that could affect evaluation of the submission.
4.2. Manuscript Checklist for Final Submission
Before submitting a manuscript, authors should confirm that:
-
The manuscript is complete, readable, and provided in an editable format.
-
The title is concise and does not contain unnecessary abbreviations or non-standard symbols.
-
Full names, institutional affiliations, and available ORCID IDs have been provided for all authors.
-
One author has been identified as the corresponding author with an active email address.
-
The abstract complies with the requirements for the relevant article type and normally does not exceed 250 words.
-
Four to seven appropriate keywords have been provided.
-
Tables are editable.
-
Figures are of adequate quality and are provided separately where required.
-
Tables and figures are numbered and cited sequentially in the text.
-
References and in-text citations correspond accurately.
-
References have been checked for completeness and accuracy.
-
Any preprint version has been disclosed and appropriately identified.
-
Page numbers are included.
-
Appropriate reporting-guideline checklists and flow diagrams have been submitted where required.
-
Clinical trial registration information has been included where applicable.
-
All applicable declarations have been included:
-
Acknowledgements;
-
Conflict of Interest;
-
Funding;
-
Authors' Contributions;
-
Data Availability;
-
Ethics Approval;
-
Informed Consent; and
-
Consent for Publication.
5. Editorial Review and Acceptance
All submissions undergo an initial editorial assessment to determine whether they fall within the journal's scope, satisfy basic scientific and ethical requirements, and are sufficiently prepared for peer review.
Manuscripts that pass the initial assessment are evaluated according to the journal's Peer Review Policy.
Research and other peer-reviewed scholarly articles are normally evaluated by at least two independent reviewers.
EJMR uses a double-blind peer-review process, under which the identities of authors and reviewers are concealed from one another during review.
Editorial decisions may include:
-
accept;
-
minor revision;
-
major revision; or
-
reject.
A manuscript may undergo more than one round of peer review where necessary.
The Editors may make reasonable editorial and language corrections to improve clarity, consistency, and presentation. Substantive changes will not be made without appropriate author involvement.
The Editor-in-Chief or appropriately delegated independent editor is responsible for the final editorial decision.
Manuscripts submitted by editors, Editorial Board members, or individuals with a potential conflict of interest will be handled independently by an editor who has no relevant conflict. The submitting editor or board member will not participate in reviewer selection or the editorial decision concerning their manuscript.
Editorial decisions are based on scientific merit, methodological quality, ethical compliance, relevance, and the journal's editorial criteria and are independent of authors' ability to pay publication charges or eligibility for waivers.
Authors who wish to challenge an editorial decision should follow the journal's Complaints and Appeals Policy.
6. Manuscripts Accepted for Publication
6.1. Proofs
Proofs of accepted manuscripts will be sent electronically to the corresponding author.
Authors should carefully review the proof for typesetting, formatting, factual, and production errors.
Proof correction is not an opportunity to substantially rewrite the manuscript or introduce new data. Substantive changes after acceptance require editorial approval.
Corrected proofs should be returned to the Editorial Office within the timeframe specified in the proof notification.
6.2. Publication Charges
All EJMR articles are published on an open-access basis and are freely available to readers immediately upon publication.
Authors must carefully review the journal's Article Processing Charges (APC) Policy before submission.
Information concerning eligibility for waivers or discounts is provided in the APC Waiver and Discount Policy.
Any applicable APC, waiver, or discount will be governed exclusively by the APC and Waiver policies displayed on the journal website at the relevant time.
No submission fee is charged.
The existence, amount, payment, waiver, or discount of an APC has no influence on editorial assessment, peer review, or the decision to accept or reject a manuscript.
For additional information about free access to published content, see the journal's Open Access Policy.
6.3. Copyright
Copyright in articles published by EJMR is retained by the author(s), subject to any rights that may belong to an employer or other lawful copyright holder.
Authors grant EJMR the non-exclusive right of first publication and the right to identify itself as the original publisher.
For complete information, see the journal's Copyright and Licensing Policy.
6.4. Publishing Rights
Authors retain copyright and publishing rights without unnecessary restrictions, subject to the terms of the Creative Commons license applied to the published article and any third-party material that is separately identified.
6.5. Licensing Policy
EJMR is an open-access journal.
Unless otherwise explicitly indicated on an individual article, articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Under CC BY 4.0, readers may share and adapt the published material for lawful purposes, including commercial purposes, provided that appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes are indicated.
EJMR does not impose additional restrictions that alter the terms of the CC BY 4.0 license.
Material within an article that is not covered by the article's Creative Commons license must be clearly identified.
For complete information, see the journal's Copyright and Licensing Policy and Open Access Policy.
6.6. Preprint Policy
EJMR considers manuscripts that have previously been posted on recognized preprint servers, provided that:
-
authors disclose the existence and location of the preprint at submission;
-
the preprint has not been formally peer reviewed and published as a journal article;
-
posting the preprint does not prevent the authors from granting EJMR the necessary non-exclusive publishing rights; and
-
the manuscript otherwise complies with EJMR's originality and publication policies.
Where an APC applies under the journal's current APC Policy, prior posting as a preprint does not alter the applicable APC or waiver arrangements.
Following publication, authors are encouraged to update the preprint record with the citation and DOI of the final EJMR article.
For further information, see the Preprint Policy.
6.7. Self-Archiving
EJMR supports author self-archiving.
Authors may deposit appropriate versions of their manuscript on personal websites, institutional repositories, subject repositories, and other appropriate scholarly repositories, in accordance with the journal's Open Access Policy and Copyright and Licensing Policy.
After publication, authors are encouraged to include the complete citation and DOI link to the final published EJMR version.
Information concerning long-term preservation of journal content is available in the Archiving Policy.
6.8. Article Corrections, Retractions, and Withdrawal
EJMR is committed to maintaining the accuracy and integrity of the scholarly record.
Corrections
Authors should promptly notify the Editorial Office if they identify a significant error in a published article.
Corrections will be evaluated by the journal and, where warranted, published transparently and linked to the original article.
Retractions
EJMR may retract an article where there is reliable evidence that its findings are seriously unreliable, the article constitutes redundant publication, plagiarism or major ethical misconduct has occurred, research was conducted unethically, or other circumstances justify retraction in accordance with accepted publication-ethics standards.
A retraction does not require the agreement of all authors when the Editor determines that retraction is necessary to preserve the integrity of the scholarly record.
A retraction notice will:
-
be clearly identified as a retraction;
-
be linked to the affected article;
-
explain the reason for the retraction to the extent appropriate;
-
identify who is retracting the article; and
-
remain permanently accessible.
The original article will normally remain available as part of the scholarly record but will be clearly marked as retracted.
For complete procedures, see the Article Correction, Retraction and Withdrawal Policy.
Withdrawal
Authors may request withdrawal of a submitted manuscript by providing a written explanation to the Editorial Office. Where appropriate, confirmation from all authors may be requested.
Authors must not assume that a manuscript has been withdrawn until formal confirmation has been received from the journal.
Published articles will not ordinarily be removed from the scholarly record except in exceptional circumstances involving legal requirements, serious privacy concerns, or other compelling reasons.
For complete procedures, see the journal's Policy for Article Withdrawal Request from Authors.
Inquiries about these guidelines should be addressed to the editorial office at editor@respublishers.com.